Life
GSK Discontinues Leucovorin Once More
In the latest health news, GSK has announced another departure from leucovorin, alongside updates on a revised ACIP charter and issues related to sports betting and gambling addiction.
editorial-staff
1 min read
Updated about 18 hours ago
Summary
GSK has confirmed its decision to discontinue leucovorin, marking yet another chapter in the drug's history.
This announcement comes amidst broader discussions in health news, including a revised charter from the Advisory Committee on Immunization Practices (ACIP).
Additionally, topics such as sports betting and gambling addiction are gaining attention, reflecting ongoing concerns in public health.
Key Facts
- Key facts pending editorial review.
Updates
- No subsequent updates recorded.